LATEST
Intelligent Protection Management agreed to acquire AdTech ITnewJanel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range Intermediate
Open App
Agreement signedPublished 14 Feb 2022

SPK Acquisition Corp. /
Varian Bio

SPK Acquisition Corp. and Varian Bio agree to merger

Price
$116m
Stage
Agreement signed
Source · 14 Feb 2022
See the source
01 / BuyerSPK Acquisition Corp.
02 / TargetVarian Bio
01

What happened

SPK Acquisition Corp. agreed to combine with Varian Bio, a precision oncology company developing cancer therapeutics, in a transaction expected to make Varian Bio publicly traded.

The combined company is expected to have a pro forma equity value of approximately $116 million, assuming no redemptions from SPK’s public shareholders. The merger is expected to close in Q2 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Source

SPK Acquisition Corp. and Varian Bio agree to merger

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Expected close

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.